Member Info for WeTookPelham

Purely IMO...despite Covidity being based on the Immunobody platform iteslf, and the huge potential of Moditope/Avidimab, I do think Covidity could overshadow them all simply because of the worldwide demand and focus of finding a Covid19 vaccine, it could catapult Scancell into the stratosphere on it's own (it's certainably bubbling under the surface atm).

I also wonder if the future focus of Scancell both short and long term could change from say 90% cancer/ 10% Covid/Viruses, to say 50% cancer 50% other illnesses/viruses? Because Immonobody has so many potential targets doesn't it? E.g. Flu etc...also wasn't HIV mentioned?

No need to apologise @wf, it's a a perfect article summarising the work that's definitely worth having a reminder of!

Think that is the article that that should be shared to newcomers.

Looking at it again it might be a subtly different/revised article, I'm not sure now!? But either way it's great to see.

Also spotted this whilst I was there:
https://www.nottingham.ac.uk/news/funding-for-covid-19-vaccine-to-clinical-trials

Lots of interesting stuff in general:
https://www.nottingham.ac.uk/search.aspx?search_keywords=Scancell

I'm sure I posted that before? lol.
But no, great to see it again nevertheless.

Oh and don't forget Scancell have a 2nd generation Covid vaccine based on a platform that's already been proven effective and tested as safe!

Puts that Abbvie deal in some context?

Whilst their pipeline isn't exactly like for like with Scancells I think!(?) (they seem to have mabs only?) I would say at a cursory glance that Scancells pipeline would be worth more if a similar type of deal was to happen...all IMO.

Interesting company, pipeline and targets though...some synergy with what Scancell do?

https://www.streetinsider.com/Corporate+News/AbbVie+%28ABBV%29+Agrees+to+%242.9B+Cancer+Treatment+Deal+with+Chinas+I-Mab+%28IMAB%29+-+Bloomberg/17326875.html?classic=1

"...AbbVie (NYSE: ABBV) and China's I-Mab Biopharma (NASDAQ: IMAB) agreed to collaborate on cancer treatments in a deal that could be worth more than $2.9 billion, according to Bloomberg. The deal gives AbbVie an exclusive license to develop and sell I-Mab cancer-fighting drugs outside greater China.

AbbVie will pay I-Mab $180 million upfront as well as $20 million based on recently-released data. It could also receive as much as $1.74 billion in milestone payments."

http://www.i-mabbiopharma.com/en/Pipeline.aspx

The figures involved are of interest perhaps?

https://www.newscientist.com/article/2253386-what-are-t-cells-and-why-have-they-become-a-political-football/amp/

Covid Vaccine Frontrunners Will Soon See Their Moment of Truth

https://www.bloombergquint.com/business/frontrunning-covid-vaccines-will-soon-see-their-moment-of-truth

@Scousemark - you're bang on the money - I'm not heeding my own advice.

Laters buttcrack/aimsmall - filtered.

@WF - obviously you won't get reply about this as:
a) it's out of their simple realm of trying to divert/making negative remarks only
b) They probably lack the intelligence to discuss the science at "any" level
c) A reply might sound positive

...when my posts get removed ;)
Too much truth perhaps?

@crumbs "This is all a boring diversion ( deliberate ) and we have seen it many times before... "

This + 1, perfectly and succintly put...basically what i was trying to say in a very long roundabout way!

Their sole aim is divert conversation and hopefully spook a few newbies (e.g. AB1234) and nothing more, It's nothing to do with debating.

I would suggest long term board memebers filter and ignore, but then I guess newbies would be exposed to their lies/ twisting of information/propaganda!

Nice work/deduction Pistol7!

...See what you started lol.
IMO whilst you're 100% entitled to ask why there is this argumentive, bulls vs bears element to the chat on here, please learn to read between the lines, understand that certain posters have agendas, and take everything you read with a pinch of salt - bullish and bearish. Oh and DYOR!
Hopefully you understand the dynamic now and we can all move on...please!

The 5.5p open offer is looking to be a very ASTUTE move atm, hopefully lots of shareholders got their allocation and extras!?
Team Doom/4.5 Bazooka Crew - hopefully you did too?

@RR...confused, why should GF123 worry about that?

AB1234 - clearly team doom/4.5 bazooka crew don't believe...or they do and just don't to admit it :).

But yes, agree Scancell looking very sure footed atm...IMO. As posted on the weekend, relatively speaking it's potentionally a very good time to buy IMO.

I hope team doom/4.5 bazooka crew have you on filter GF123 :)

https://www.theguardian.com/world/2020/aug/28/uk-emergency-approval-covid-vaccine-breakthrough

"Legal change will enable population to be immunised as quickly as possible"

"Any new and effective Covid vaccine will be given emergency approval for use in the UK and an expanded workforce will be trained to give the injections to immunise as much of the population as possible quickly, the government has said."

TF I believe Cliff Holloway said the total was £2.7m, Scancell getting the bulk of it as they were doing most of the "heavy lifting".